Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
0.9542
Dollar change
+0.0178
Percentage change
1.90
%
IndexRUT P/E- EPS (ttm)-1.90 Insider Own59.35% Shs Outstand42.18M Perf Week-9.12%
Market Cap53.51M Forward P/E- EPS next Y-1.48 Insider Trans0.00% Shs Float22.37M Perf Month-27.71%
Income-131.52M PEG- EPS next Q-0.47 Inst Own35.27% Short Float12.95% Perf Quarter-80.76%
Sales3.00M P/S17.84 EPS this Y11.63% Inst Trans18.77% Short Ratio7.87 Perf Half Y-74.55%
Book/sh2.84 P/B0.34 EPS next Y17.09% ROA-57.72% Short Interest2.90M Perf Year-67.10%
Cash/sh2.74 P/C0.35 EPS next 5Y30.10% ROE-66.64% 52W Range0.92 - 6.80 Perf YTD-77.65%
Dividend Est.- P/FCF- EPS past 5Y-43.14% ROI-76.53% 52W High-85.97% Beta1.48
Dividend TTM- Quick Ratio7.04 Sales past 5Y0.00% Gross Margin46.20% 52W Low4.25% ATR (14)0.09
Dividend Ex-Date- Current Ratio7.04 EPS Y/Y TTM12.47% Oper. Margin-4775.40% RSI (14)28.91 Volatility7.44% 7.01%
Employees128 Debt/Eq0.12 Sales Y/Y TTM- Profit Margin-4383.90% Recom3.00 Target Price4.25
Option/ShortYes / Yes LT Debt/Eq0.10 EPS Q/Q5.99% Payout- Rel Volume0.82 Prev Close0.94
Sales Surprise- EPS Surprise8.90% Sales Q/Q- EarningsNov 06 AMC Avg Volume368.25K Price0.95
SMA20-6.25% SMA50-33.68% SMA200-73.92% Trades Volume302,727 Change1.90%
Date Action Analyst Rating Change Price Target Change
Sep-19-24Upgrade H.C. Wainwright Neutral → Buy $5
Jun-20-24Downgrade Barclays Equal Weight → Underweight $3
Mar-13-24Initiated JMP Securities Mkt Outperform $7
Feb-20-24Downgrade H.C. Wainwright Buy → Neutral $5
Dec-19-23Downgrade Morgan Stanley Equal-Weight → Underweight $10 → $4
Nov-21-22Downgrade BofA Securities Neutral → Underperform $8 → $6
Sep-09-22Downgrade Morgan Stanley Overweight → Equal-Weight $19 → $11
Jul-29-22Initiated Jefferies Buy $9
Mar-15-22Downgrade BofA Securities Buy → Neutral $50 → $10
Feb-28-22Downgrade Barclays Overweight → Equal Weight $20 → $12
Nov-27-24 09:35AM
07:30AM
Nov-11-24 09:35AM
Nov-06-24 04:05PM
Oct-27-24 01:15PM
07:30AM Loading…
Oct-24-24 07:30AM
Oct-09-24 07:30AM
Sep-13-24 10:00AM
Sep-09-24 07:30AM
Aug-29-24 09:33AM
Aug-12-24 07:01AM
Jul-10-24 06:53AM
Jul-09-24 07:30AM
Jun-20-24 09:54AM
Jun-03-24 07:01AM
07:01AM Loading…
May-09-24 07:01AM
May-07-24 01:53PM
07:01AM
Apr-09-24 04:35PM
Mar-05-24 04:45PM
Feb-29-24 04:05PM
Feb-15-24 04:05PM
Dec-11-23 09:34AM
Nov-03-23 08:42AM
05:55AM
Nov-01-23 04:10PM
04:05PM
Oct-14-23 12:30PM
Oct-04-23 12:00PM
Aug-29-23 08:30AM
09:56AM Loading…
Aug-17-23 09:56AM
Aug-03-23 08:00AM
Jul-10-23 08:13AM
Jun-02-23 11:36AM
May-31-23 08:30AM
May-28-23 08:11AM
May-18-23 07:00AM
May-17-23 04:08PM
May-08-23 08:30AM
Apr-27-23 08:30AM
Apr-11-23 08:30AM
Apr-07-23 09:34AM
Mar-18-23 06:48PM
Mar-16-23 12:06PM
Mar-15-23 08:30AM
08:00AM
Mar-01-23 08:30AM
Feb-09-23 09:05AM
Jan-30-23 09:38AM
Dec-24-22 07:05AM
Nov-25-22 08:06AM
Nov-14-22 08:00AM
Oct-18-22 08:00AM
Sep-06-22 08:00AM
Aug-23-22 06:39AM
Aug-10-22 09:25AM
Aug-09-22 08:00AM
Jul-05-22 09:22PM
Jun-22-22 09:55AM
May-25-22 06:35AM
May-10-22 08:00AM
Mar-16-22 07:30AM
06:39AM
Mar-11-22 08:00AM
Mar-09-22 08:05AM
08:00AM
Feb-11-22 07:00AM
Jan-04-22 07:00AM
Dec-24-21 12:38AM
Dec-18-21 12:38AM
Dec-16-21 09:41AM
Dec-15-21 07:15PM
Dec-08-21 08:47AM
Nov-23-21 07:00AM
Nov-19-21 11:51AM
Nov-12-21 08:00AM
Nov-08-21 09:00AM
Oct-18-21 08:24PM
Oct-07-21 03:12PM
12:55PM
12:28PM
11:15AM
10:16AM
09:00AM
Sep-25-21 10:06AM
Sep-09-21 07:07PM
Sep-02-21 07:00AM
Aug-12-21 07:30AM
Aug-11-21 06:49AM
Jul-19-21 07:00AM
May-13-21 07:15AM
May-11-21 07:30AM
May-05-21 07:00AM
Apr-20-21 07:42AM
Mar-16-21 08:00AM
Mar-03-21 07:00AM
Jan-11-21 06:20PM
Jan-07-21 12:12AM
Jan-04-21 04:16PM
Dec-25-20 04:01AM
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.